Cargando…
Cardiovascular risk in newly diagnosed type 2 diabetes patients in India
BACKGROUND: Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970505/ https://www.ncbi.nlm.nih.gov/pubmed/35358208 http://dx.doi.org/10.1371/journal.pone.0263619 |
_version_ | 1784679471228387328 |
---|---|
author | Unnikrishnan, A. G. Sahay, R. K. Phadke, Uday Sharma, S. K. Shah, Parag Shukla, Rishi Viswanathan, Vijay Wangnoo, S. K. Singhal, Santosh John, Mathew Kumar, Ajay Dharmalingam, Mala Jain, Subodh Shaikh, Shehla Verberk, Willem J. |
author_facet | Unnikrishnan, A. G. Sahay, R. K. Phadke, Uday Sharma, S. K. Shah, Parag Shukla, Rishi Viswanathan, Vijay Wangnoo, S. K. Singhal, Santosh John, Mathew Kumar, Ajay Dharmalingam, Mala Jain, Subodh Shaikh, Shehla Verberk, Willem J. |
author_sort | Unnikrishnan, A. G. |
collection | PubMed |
description | BACKGROUND: Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is still limited. The aim of this study was to understand the extent of cardiovascular disease (CVD) risk of newly diagnosed T2DM patients in India. METHODS: A cross sectional observational study was conducted to evaluate clinical laboratory and socio-demographic parameters of 5,080 newly diagnosed T2DM patients (48.3 ± 12.8 years of age; 36.7% female). In addition, we determined their cardiovascular risk according to the guidelines of the Lipid Association of India (LAI) and the criteria of the QRISK3 score. RESULTS: Of the newly T2DM diagnosed patients in India 2,007(39.5%) were classified as “High risk” and 3,073 (60.5%) were classified as “Very high risk” based on LAI criteria. On average, patients had 1.7 ± 0.9 major atherosclerotic cardiovascular disease (ASCVD) risk factors. Low HDL-C value was the most frequent major risk (2,823; 55.6%) followed by high age (2,502; 49.3%), hypertension (2,141; 42.1%), smoking/tobacco use (1,078; 21.2%) and chronic kidney disease stage 3b or higher (568; 11.2%). In addition, 4,192 (82.5%) patients appeared to have at least one cholesterol abnormality and, if the latest LAI recommendations are applied, 96.5% (4,902) presented with lipid values above recommended targets. Based on the QRISK3 calculation Indian diabetes patients had an average CVD risk of 15.3 ± 12.3%, (12.2 ± 10.1 vs. 17.1 ± 13.5 [p<0.001] for females and males, respectively). CONCLUSIONS: Newly diagnosed Indian T2DM patients are at high ASCVD risk. Our data therefore support the notion that further extension of nationwide ASCVD risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted. |
format | Online Article Text |
id | pubmed-8970505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-89705052022-04-01 Cardiovascular risk in newly diagnosed type 2 diabetes patients in India Unnikrishnan, A. G. Sahay, R. K. Phadke, Uday Sharma, S. K. Shah, Parag Shukla, Rishi Viswanathan, Vijay Wangnoo, S. K. Singhal, Santosh John, Mathew Kumar, Ajay Dharmalingam, Mala Jain, Subodh Shaikh, Shehla Verberk, Willem J. PLoS One Research Article BACKGROUND: Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is still limited. The aim of this study was to understand the extent of cardiovascular disease (CVD) risk of newly diagnosed T2DM patients in India. METHODS: A cross sectional observational study was conducted to evaluate clinical laboratory and socio-demographic parameters of 5,080 newly diagnosed T2DM patients (48.3 ± 12.8 years of age; 36.7% female). In addition, we determined their cardiovascular risk according to the guidelines of the Lipid Association of India (LAI) and the criteria of the QRISK3 score. RESULTS: Of the newly T2DM diagnosed patients in India 2,007(39.5%) were classified as “High risk” and 3,073 (60.5%) were classified as “Very high risk” based on LAI criteria. On average, patients had 1.7 ± 0.9 major atherosclerotic cardiovascular disease (ASCVD) risk factors. Low HDL-C value was the most frequent major risk (2,823; 55.6%) followed by high age (2,502; 49.3%), hypertension (2,141; 42.1%), smoking/tobacco use (1,078; 21.2%) and chronic kidney disease stage 3b or higher (568; 11.2%). In addition, 4,192 (82.5%) patients appeared to have at least one cholesterol abnormality and, if the latest LAI recommendations are applied, 96.5% (4,902) presented with lipid values above recommended targets. Based on the QRISK3 calculation Indian diabetes patients had an average CVD risk of 15.3 ± 12.3%, (12.2 ± 10.1 vs. 17.1 ± 13.5 [p<0.001] for females and males, respectively). CONCLUSIONS: Newly diagnosed Indian T2DM patients are at high ASCVD risk. Our data therefore support the notion that further extension of nationwide ASCVD risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted. Public Library of Science 2022-03-31 /pmc/articles/PMC8970505/ /pubmed/35358208 http://dx.doi.org/10.1371/journal.pone.0263619 Text en © 2022 Unnikrishnan et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Unnikrishnan, A. G. Sahay, R. K. Phadke, Uday Sharma, S. K. Shah, Parag Shukla, Rishi Viswanathan, Vijay Wangnoo, S. K. Singhal, Santosh John, Mathew Kumar, Ajay Dharmalingam, Mala Jain, Subodh Shaikh, Shehla Verberk, Willem J. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India |
title | Cardiovascular risk in newly diagnosed type 2 diabetes patients in India |
title_full | Cardiovascular risk in newly diagnosed type 2 diabetes patients in India |
title_fullStr | Cardiovascular risk in newly diagnosed type 2 diabetes patients in India |
title_full_unstemmed | Cardiovascular risk in newly diagnosed type 2 diabetes patients in India |
title_short | Cardiovascular risk in newly diagnosed type 2 diabetes patients in India |
title_sort | cardiovascular risk in newly diagnosed type 2 diabetes patients in india |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970505/ https://www.ncbi.nlm.nih.gov/pubmed/35358208 http://dx.doi.org/10.1371/journal.pone.0263619 |
work_keys_str_mv | AT unnikrishnanag cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT sahayrk cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT phadkeuday cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT sharmask cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT shahparag cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT shuklarishi cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT viswanathanvijay cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT wangnoosk cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT singhalsantosh cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT johnmathew cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT kumarajay cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT dharmalingammala cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT jainsubodh cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT shaikhshehla cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia AT verberkwillemj cardiovascularriskinnewlydiagnosedtype2diabetespatientsinindia |